Library Quick Links
Search Our Collections
Ask Us
Help Yourself
Borrowing & Ordering
About Us
Behar E, Chin JJ
New York: Division of Health Policy, New York Academy of Medicine, 2006.
Wilson TE, Vlahov D, Crystal S, Absalon J, Klein SJ, Remein RH, Agins B. Integrating HIV prevention activities into the HIV medical care setting: a report from the NYC HIV Centers Consortium. J Urban Health. 2006; 83(1):18-30.
Frye V, Latka MH, Koblin B, Halkitis PN, Putnam S, Galea S, Vlahov D. The urban environment and sexual risk behavior among men who have sex with men. J Urban Health. 2006; 83(2):308-24.
Freudenberg N, Fahs M, Galea S, Greenberg A. The impact of New York City’s 1975 fiscal crisis on the tuberculosis, HIV, and homicide syndemic. American Journal of Public Health. 2006; 96(3):561-567.
Vlahov D, Putnam S. From corrections to communities as an HIV priority. J Urban Health. 2006; 83(3):339-48.
Confrancesco J, Shah N, Ghanem K, Dobs A, Klein RS, Mayer K, Schuman P, Vlahov D, Rompalo AM. The Effects Of Illicit Drug Use And HIV Infection On Sex Hormone Levels In Women. Gyne Endocrin. 2006; 22 (5):244-251. Available
Weiss L, French T, Waters M, Netherland J, Agins B, Finkelstein R . Adherence to HAART: Perspectives from clients in treatment support programs. Psychology, Health & Medicine. 2006; 11(2):155-170.
Bower WA, Culver DH, Castor D, Wu Y, James VN, Zheng H, Hammer S, Kuhnert WL, Williams IT, Bell BP, Vlahov D, Dezzutti CS. Changes in Hepatitis C Virus (HCV) Viral Load And Interferon-Alpha Levels in HIV/HCV-Coinfected Patients Treated With Hight Active Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2006; Available
Ickovics JR, Milan S, Boland R, Schoinbaum E, Schuman P, Vlahov D. Psychological resources protect health: 5-year survival and immune function among HIV-infected women from four US cities. AIDS. 2006; 11;20(14):1851-1860.
Mannheimer, SB, Mukherjee, R, Hirschhorn, LR, Dougherty, J, Celano, SA, Ciccarone, D, Graham, KK, Mantell, JE, Mundy, LM, Eldred, L, Botsko, M, Finkelstein, R. The CASE Adherence Index: A Novel Method for Measuring Adherence to Antiretroviral Therapy. AIDS Care. 2006; 18(7):853-861.
Smit E, Crespo CJ, Semba RD, Jaworowicz D, Vlahov D, Ricketts EP, Ramirez-Marrero FA, Tang AM. Physical activity in a cohort of HIV-positive and HIV-negative injection drug users. AIDS Care. 2006; 18(8):1040-5.
Mehta SH, Galai N, Astemborski J, Celentano DD, Strathdee SA, Vlahov D, Nelson KE. Brief Report: HIV Incidence Among Injection Drug Users in Baltimore, Maryland (1988-2004). J Acquir Immune Defic Syndr. 2006; 43(3):368-372.
Deren S, Cleland CM, Fuller C, Kang SY, Des Jarlais DC, Vlahov D. The Impact of Syringe Deregulation on Sources of Syringes for Injection Drug Users: Preliminary Finding. AIDS Behav. 2006; 10(6):717-21.
2005 Publications
Sterling TR, Pisell-Noland T, Perez JL, Astemborski J, McGriff JR, Nutting L, Hoover DR, Vlahov D, Bollinger RC. Sex-based differences in T lymphocyte responses in HIV-1-seropositive individuals. J Infect Dis. 2005; 191:881-885. Available
Smit E, Semba RD, Pilibosian E, Vlahov D, Tun W, Purvis L, Tang AM.. Body habitus in a cohort of HIV-seronegative injection drug users. AIDS Patient Care STDS. 2005; 19(1):19-30. Available
Galai N, Vlahov D, Bareta JC, Wang C, Cohn S, Sterling TR. Prognostic factors for survival differ according to CD4+ cell count among HIV-infected injection drug users: pre-HAART and HAART eras. Journal of Acquired Immune Deficiency Syndromes. 2005; 38(1):74-81. Available
Lai S, Lima JAC, Hong L, Vlahov D, Celentano D, Tong W, Bartlett JG, Margolick J, Fishman EK. Human immunodeficiency virus 1 infection, cocaine, and coronary calcification. Arch Intern Med. 2005; 165:690-695. Available
Duggal P, Winkler CA, An P, Yu M, Farzadegan F, O’Brien SH, Beaty TH, Vlahov D. The effect of RANTES chemokine genetic variants on HIV-1 plasma RNA among African American injection drug users. J Acquir Immune Defic Syndr. 2005; 38(5):584-589. Available
Vlahov D, Galai N, Safaeian M, Galea S, Kirk GD, Lucas GM, Sterling TM. Effectiveness of highly antiretroviral therapy among injection drug users with late-stage human immunodeficiency virus infection. Am J Epidemiol. 2005; 161:1-14.
Vlahov D, Galai N, Safaeian M, Galea S, Kirk GD, Lucas GM, Sterling TR.. Effectiveness of highly active antiretroviral therapy among injection drug users with late-stage human immunodeficiency virus infection. Am J Epidemiol. 2005; 161:999-1012. Available
Kapadia F, Cook JA, Cohen MH, Sohler N, Kovacs A, Greenblatt RM, Choudhary I, Vlahov D. The relationship between non-injection drug use behaviors on progression to AIDS and death in a cohort of HIV seropositive women in the era of highly active antiretroviral therapy use. Addiction. 2005; 100(7):990-1002. Available
Kapadia F, Vlahov D, Donahoe RM, Friedland G. The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations. Clin Infect Dis. 2005; 41(7):1027-34.
Golub ET, Purvis LA, Sapun M, Sagaeian M, Beyrer C, Vlahov D, Strathdee SA. Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users. AIDS Behav. 2005; 1-9. Available
Rusch ML, Farzadegan H, Tarwater PM, Safaeian M, Vlahov D, Strathdee S. Sexual risk behavior among injection drug users before widespread availability of highly active antiretroviral therapy. AIDS Behav. 2005; 1-11.
Milan S, Ickovics J, Vlahov D, Boland R, Schoenbaum E, Schuman P, Moore J. Interpersonal predictors of depression trajectories in women with HIV. J Consult Clin Psychol. 2005; 73(4):678-88.
Latka MH, Wilson TE, Cook JA, Bacon MC, Richardson JL, Sohler N, Cohen MH, Greenblatt RM, Andreopoulos E, Vlahov D. Impact of drug treatment on subsequent sexual risk behavior in a multisite cohort of drug-using women: a report from the Women’s Interagency HIV Study. J Subst Abuse Treat. 2005; 29(4):329-37.
Shrestha S, Strathdee SA, Galai N, Oleksyk T, Fallin MD, Mehta S, Schaid D, Vlahov D, O’Brien SJ, Smith MW. Behavioral risk exposure and host genetics of susceptibility to HIV-1 infection. J Infect Dis. 2005; 193(1):16-26.
Modi WS, Scott K, Goedert JJ, Vlahov D, Buchbinder S, Detels R, Donfield S, O’Brien SJ. Haplotype analysis of the SDF-1 (CXCL12) gene in a longitudinal HIV-1/AIDS cohort study. Genes Immun. 2005; 6(8):691-8. Available
Chin JJ, Mantell J. Weiss L, Bhagavan M, Luo X. Chinese and South Asian Religious Institutions and HIV Prevention in New York City. AIDS Education and Prevention. 2005; 17:484-502. Available
IN: Public financing and Delivery of HIV/AIDS Care: Securing the Legacy of Ryan White.
Washington DC: National Academies Press, 2005.
Available
Fuller CM, Absalon J, Ompad D, Nash D, Koblin B, Blaney S, Galea S, Vlahov D. A comparison of HIV seropositive and seronegative young adult heroin- and cocaine-using men who have sex with men in New York City, 2000-2003. J Urban Health. 2005; 82(1) Suppl.1:151-161. Available
Finkelstein Ruth. Ryan White CARE Act Reauthorization 2005: Title I and Title II Health Services Expenditures Patterns. Examination of Fiscal Management and the Allocation of CARE Act Resources. 2005; 1-7.
Rusch ML, Farzadegan H, Tarwater PM, Safaeian M, Vlahov D, Strathdee S. Sexual risk behavior among injection drug users before widespread availability of highly active antiretroviral therapy. AIDS Behav. 2005; 9(3):1-11.
Schackman BR, Finkelstein R, Neukermans CP, Lewis L, Eldred L. The Cost of HIV Medication Adherence Support Interventions: Results of a Cross-site Evaluation. AIDS Care. 2005; 17(8):927-937. Available
French T, Weiss L, Waters M, Tesoriero J, Finkelstein R, Agins B. Correlation of a Brief Perceived Stress Measure With Nonadherence to Antiretroviral Therapy Over Time. Journal of Acquired Immune Deficiency Snydrome. 2005; 38:5:590-597.
2004 Publications
Dezzutti CS, Astemborski J, Thomas DL, Marshall JH, Cabrera T, Purdy M, Vlahov D, Garfein RS. Prevalence of cryoglobulinemia in hepatitis C virus (HCV) positive patients with and without human immunodeficiency virus (HIV) coinfection. Journal of Clinical Virology. 2004; 31:210-214. Available
Dorrucci M, Valdarchi C, Suligoi B, Zaccarelli, Sinicco A, Giuliami M, Vlahov D, Pezzotti P, Rezza G and the Italian HIV Seroconversion Study. The effect of hepatitis C on progression to AIDS before and after highly active antiretroviral therapy. AIDS. 2004; 18(17):2313-8. Available
Martin MP, Lederman MM, Hutcheson HB, Goedert JJ, Nelson GW, van Kooyk Y, Detels R, Buchbinder S, Hoots K, Vlahov D, O’Brien SJ, Carrington M. Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection. Journal of Virology. 2004; 78(24):14053-6. Available
Coffin PO, Fuller C, Blaney S, Vadnai L, Miller S, Vlahov D. Syringe distribution to injection drug users for prevention of HIV infection: opinions and practices of health care providers in New York City. Clinical Infectious Diseases. 2004; 38(3):438-41. Available
Sethi AK, Celentano DD, Gange SJ, Gallant JE, Vlahov D, Farzadegan H. High-risk behavior and potential transmission of drug-resistant HIV among injection drug users. JAIDS: Journal of Acquired Immune Deficiency Syndromes. 2004; 35(5):503-510. Available
Rompalo AM, Shah N, Margolick JB, Farzadegan H, Arnsten J, Schuman P, Rich JD, Gardner LI, Smith DK, Vlahov D: HIV Epidemiology Research Study Group. Evaluation of possible effects of continued drug use on HIV progression among women. International Journal of STD & AIDS. 2004; 15(5):322-7. Available
Garfein RS, Monterroso ER, Tong TC, Vlahov D, Des Jarlais DC, Selwyn P, Kerndt PR, Word C, Fernando MD, Ouellet LJ, Homberg SD. Comparison of HIV infection risk behaviors among injection drug users from east and west coast US cities. Journal of Urban Health: Bulletin of the New York Academy of Medicine. 2004; 81(2):260-7. Available
Macalino GE, Vlahov D, Sanford-Colby S, Patel S, Sabin K, Salas C, Rich JD. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. American Journal of Public Health. 2004; 94(7):1218-23. Available
Hamburger ME, Moore J, Koenig LJ, Vlahov D, Schoenbaum EE, Schuman P, Mayer K for the HIV Epidemiology Research Study Group. Persistance of inconsistant condom use: relation to abuse history and HIV serostatus. AIDS and Behavior. 2004; 8(3):333-334. Available
Wang C, Vlahov D, Galai N, Bareta J, Strathdee SA, Nelson KE, Sterling TR. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy. Journal of Infectious Diseases. 2004; 190(6):1046-54. Available
An P, Bleiber G, Duggal P, Nelson G, May M, Mangeat B, Alobwede I, Trono D, Vlahov D, Donfield S, Goedert JJ, Phair J, Buchbinder S, O'Brien SJ, Telenti A, Winkler CA. APOBEC3G genetic variants and their influence on the progression to AIDS. Journal of Virology. 2004; 78:11070-11076. Available
Purcell DW, Metsch LR, Latka M, Santibanez S, Gomez CA, Eldred L, Latkin CA: for the INSPIRE Study Group. Interventions for seropositive injectors-research and evaluations: an integrated behavioral intervention with HIV-positive injection drug users to address medical care, adherence, and risk reduction. Journal of Acquired Immune Deficiency Syndromes. 2004; 37:S110-S118. Available
Winkler CA, Hendel H, Carrington M, Smith MW, Nelson GW, O'Brien SJ, Phair J, Vlahov D, Jacobson LP, Rappaport J, Vasilescu A, Bertin-Maghit S, An P, Lu W, Andrieu JM, Schachter F, Therwath A, Zagury JF. Dominant effects of CCR2-CCR5 haplotypes in HIV-1 disease progression. Journal of Acquired Immune Deficiency Syndromes. 2004; 37(4):1534-8. Available
2003 Publications
Latka M. Drug-using women need comprehensive sexual risk reduction interventions. Clin Infect Dis. 2003; 37(Suppl 5):S445-S450. Available
Modi MS, Winkler C, Goedert J, Vlahov D, Buchbinder S, Phair J, Donnfield S, O'Brian SJ. Contrasting influence of eotaxin chemokine gene alleles, on HIV-1 transmission and AIDS progression. AIDS. 2003; 17:2357-65.
IN: Ethnicity and HIV: Prevention and Care in Europe and the USA..
Erwin JT, Smith DK, Peters BS (eds)
London: International Medical Press, 2003.
Available
Fuller CM, Vlahov D, et al. . Social circumstances of initiation of injection drug use and early shooting gallery attendance: Implications for HIV intervention among adolescent and young adult injection drug users. Journal of Acquired Immune Deficiency Syndrome. 2003; 32(1):86-93. Available
Friedman SR,...Ompad DC et al.. HIV prevalence, risk behaviors, and high-risk sexual and injection networks among young women injectors who have sex with women. American Journal of Public Health. 2003; 93(6):902-906. Available
Mulherin SA, O'Brien T, Ioannidis J, Goedert J, Buchbinder S, Coutinho R, Jamieson B, Mayer L, Michael N, Pantaleo G, Rizzardi G, Schuitemaker H, Sheppard H, Theodorou I, Vlahov D, Rosenberg P. Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection. AIDS. 2003; 17(3):377-87. Available
French PP, Latka M, et al.. Use-effectiveness of the female versus male condom in preventing sexually transmitted disease in women. Sexually Transmitted Diseases. 2003; 30(5):433-439. Available
Des Jarlais, DC,...Diaz T,...Vlahov D,...Latka M,...Edwards V.... Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. American Journal of Epidemiology. 2003; 157(5):467-71. Available
Mantell JE, Hoffman S, Exner TM, Stein ZA, Atkins K. Family planning providers' perspectives on dual protection. Perspectives on Sexual and Reproductive Health. 2003; 35(2):71-8. Available
Golub ET,...Vlahov D,.... Psychological distress and progression to AIDS in a cohort of injection drug users. Journal of Acquired Immune Deficiency Syndromes. 2003; 32(4):429-34. Available
Stover CT,...,Vlahov D et al.. Prevalence of and risk factors for viral infections among human immunodeficiency virus (HIV)-infected and high-risk HIV-uninfected women. Journal of Infectious Diseases. 2003; 187(9):1388-96. Available
Lai S, Lai H, Celentano DD, Vlahov D, Ren S, Margolick J, Lima JAC, Bartlett JG. Factors associated with accelerated atherosclerosis in HIV-1 infected persons treated with protease inhibitors. AIDS Patient Care and STDs. 2003; 17(5):211-9. Available
Check-Modi WS, O'Brien TR, Vlahov D, Buchbinder S, Gomperts E, Phair J, O'Brien SJ, Winkler C. Haplotype diversity in the interleukin-4 gene is not associated with HIV-1 transmission and AIDS progression. Immunogenetics. 2003; 55(3):157-164.
Duggal P, An P, Beaty TH, Strathdee SA, Farzadegan H, Markham RB, Johnson L, O'Brien SJ, Vlahov D, Winkler CA. Genetic influence of CSCR6 chemokine receptor alleles on PCP mediated AIDS progression amoung African Americans. Genes and Immunity. 2003; 4(4):245-250.
Check-Modi WS, O'Brien TR, Vlahov D, Buchbinder S, Gomperts E, Phair J, O'Brien SJ, Winkler C. Haplotype diversity in the interleukin-4 gene is not associated with HIV-1 transmission and AIDS progression. Immunogenetics. 2003; 55(3):157-64.
An P, Vlahov D, Margolick JB, Phair J, O'Brien TR, Lautenberger J, O'Brien SJ, Winkler CA. A tumor necrosis factor-alpha-inducible promoter variant of interferon-gamma accelerates CD4+T cell depletion in human immunodeficiency virus-1-infected individuals. Journal of Infectious Diseases. 2003; 188(2):228-31. Available
Mayer KH, Hogan JW, Smith D, Klein RS, Schuman P, Margolick JB, Korkontzelou C, Farzedegan H, Vlahov D, Carpenter CC, HIV Epidemiology Research Study (HERS) Group. Clinical and immunologic progression in HIV-infected US women before and after the introduction of highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes. 2003; 33(5):614-24. Available
Pilowsky DJ, Zybert PA, Hsieh PW, Vlahov D, Susser E. Children of HIV-positive drug-using parents. Journal of the American Academy of Child and Adolescent Psychiatry. 2003; 42(8):950-6. Available
Wolfe R, Lobozzo J, Frye V, Sharp V. Screening for substance use, sexual practices, mental illness, and domestic violence in HIV primary care. JAIDS: Journal of Acquired Immune Deficiency Syndromes. 2003; 33(4):548-9. Available
Tesoriero J, French T, Weiss L, Waters M, Finkelstein R. Stability of adherence to highly active antiretroviral therapy over time amoung clients enrolled in the treatment adherence domonstration project. JAIDS: Journal of Acquired Immune Deficiency Syndromes. 2003; 33(4):484-93. Available
Tun W, Celentano D, Vlahov D, Strathdee S. Attitudes toward HIV treatments influence unsafe sexual and injection practices amoung injecting drug users. AIDS. 2003; 17(13):1953-62. Available
Zwahlen M, Vlahov D. Commentary: modeling and understanding differences in human immunodeficiency and hepatitis C virus epidemiology in injection drug users. International Journal of Epidemiology. 2003; 32(5):715-6. Available
Normand JL, Lambert EY, Vlahov D. Understanding the dynamics of sexual transmission of HIV among drug-using populations: an integration of biological, behavioral, and environmental perspectives. Journal of Urban Health. 2003; 80(4 Suppl 3):iii1-6. Available
Royal W, Vlahov D, Lyles C, Gajewski CD. Retinoids and drugs of abuse: implications for neurological disease risk in Human Immunodeficiency Virus type 1 infection. Clinical Infectious Diseases. 2003; 37 Suppl 5:S427-32. Available
Weiss L, French T, Finkelstein R, Waters M, Mukherjee R, Agins B. HIV-related knowledge and adherence to HAART. AIDS Care. 2003; 15(5):673-679.
Yoshikawa H, Wilson PA, Hsueh J, Rosman EA, Chin J, Kim JH. What front-line CBO staff can tell us about culturally anchored theories of behavior change in HIV prevention for Asian/Pacific Islanders. American Journal of Community Psychology. 2003; 32(1-2):143-58. Available
2002 Publications
New York: Office of Special Populations, New York Academy of Medicine, 2002.
Available
Vlahov D.. Epidemiologic studies of illicit drug use as a cofactor for HIV progression.. Clarifying the Controversy about Whether Drug Abuse Influences AIDS Progression, NIDA Satellite Sessions in Association with the XIV International AIDS Conference. 2002; Available
Semba RD,...,Vlahov D.. Risk factors and cumulative incidence of anaemia among HIV-infected injection drug users. International Journal of STD & AIDS. 2002; 13(2):119-23. Available
Bounik AD,...,Vlahov D et al.. Highly active antiretroviral treatment does not increase sexual risk behaviour among French HIV infected injecting drug users. Journal of Epidemiology and Community Health. 2002; 56(5):349-53. Available
An P,...,Vlahov D.. Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proceedings of the National Academy of Science of the United States of America. 2002; 99(15):10002-7. Available
Meng Q,...,Vlahov D, et al.. Use of HIV protease inhibitors is associated with left ventricular morphologic changes and diastolic dysfunction. Journal of Acquired Immune Deficiency Syndrome. 2002; 30(3):306-10. Available
Martin SH,...,Vlahov D et al.. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nature Genetics. 2002; 31(4):429-34.
Downer MV,...,Vlahov D et al.. Regional variation in CCR5-Delta32 gene distribution among women from the US HIV Epidemiology Research Study (HERS). Genes and Immunity. 2002; 3(5):295-8.
Meng Q,...,Vlahov D, et al.. Coronary artery calcification, atherogenic lipid changes, and increased erythrocyte volume in black injection drug users infected with human immunodeficiency virus-1 treated with protease inhibitors. American Heart Journal. 2002; 144(4):642-8. Available
Nelson KE,...,Vlahov D.. Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998. American Journal of Epidemiology. 2002; 156(7):641-53. Available
Sheu M,...,Vlahov D, et al.. Continuity of medical care and risk of incarceration in HIV-positive and high-risk HIV-negative women. Journal of Womens Health (Larchmt). 2002; 11(8):743-50. Available
Macalino GE,...,Vlahov D.. Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users.. AIDS Education and Prevention. 2002; 14(5):367-78. Available
Howard AA,...,Vlahov D et al.. A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS. 2002; 16(16):2175-82. Available
Gruskin L, ..., Vlahov D.. Incidence of Violence Against HIV-Infected and Uninfected Women: Findings from the HIV Epidemiology Research (HER) Study. Journal of Urban Health. 2002; 79(4):512-24. Available
2001 Publications
Sambamoorthi U,...Collins S, et al.. Dually eligible individuals with AIDS: characteristics and health services use. Journal of Health and Social Policy. 2001; 14(1):19-35.
Celentano DD,... Vlahov D, et al. Dynamics of behavioral risk factors for HIV/AIDS: a 6-year prospective study of injection drug users. Drug and Alcohol Dependence. 2001; 61(3):315-22. Available
Cannon MJ,... Vlahov D, et al. Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. New England Journal of Medicine. 2001; 344(9):637-43. Available
Ickovics JR,... Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA: the Journal of the American Medical Association. 2001; 285(11):1466-74. Available
Moatti JP,...Vlahov D, et al. Multiple access to sterile syringes for injection drug users: vending machines, needle exchange programs and legal pharmacy sales in Marseille, France. European Addiction Research. 2001; 7(1):40-5.
Sterling TR,...Vlahov D, et al. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. New England Journal of Medicine. 2001; 344(10):720-5. Available
Valente TW, Vlahov D. Selective risk taking among needle exchange participants: implications for supplemental interventions. American Journal of Public Health. 2001; 91(3):406-11.
Semba RD,...Vlahov D, et al. Improvement of anemia among HIV-infected injection drug users receiving highly active antiretroviral therapy. JAIDS: Journal of Acquired Immune Deficiency Syndromes. 2001; 26(4):315-9.
Mao Q,...Vlahov D, et al. Human immunodeficiency virus seroconversion and evolution of the hepatitis C virus quasispecies. Journal of Virology. 2001; 75(7):3259-67. Available
Diaz T,... Vlahov D, et al. Sexual orientation and HIV infection prevalence among young Latino injection drug users in Harlem. Journal of Women's Health & Gender-Based Medicine. 2001; 10(4):371-80. Available
Gao X,... Vlahov D, et al. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. New England Journal of Medicine. 2001; 344(22):1668-75. Available
Strathdee SA,...Vlahov D, et al. Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Archives of Internal Medicine. 2001; 2001:161(10). Available
Valente TW,... Vlahov D, et al. Needle-exchange participation, effectiveness, and policy: syringe relay, gender, and the paradox of public health. Journal of Urban Health: Bulletin of The New York Academy of Medicine. 2001; 78(2):340-9. Available
Celentano DD,... Vlahov D, et al. Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS. 2001; 15(13):1707-15. Available
Rompalo AM,...Vlahov D. Influence of injection drug use behavior on reported antiretroviral therapy use among women in the HIV epidemiology research study: on-site versus referral care. JAIDS: Journal of Acquired Immune Deficiency Syndromes. 2001; 28(1):28-34. Available
Semba RD,...Vlahov D. Highly active antiretroviral therapy associated with improved anemia among HIV-infected women. AIDS Patient Care and STDs. 2001; 15(9):473-80.
Knowlton AR...Vlahov D, et al. Access to medical care and service utilization among injection drug users with HIV/AIDS. Drug and Alcohol Dependence. 2001; 64(1):55-62.
Gollub EL, French P, Latka M, et al. Achieving safer sex with choice: studying a women's sexual risk reduction hierarchy in an STD clinic. Journal of Women's Health & Gender-Based Medicine. 2001; 10(8):771-83. Available
Ioannidis JP,...Vlahov D, et al. Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. Annals of Internal Medicine. 2001; 135(9):782-95. Available
Vlahov D, et al. Sexual and drug risk-related behaviours after initiating highly active antiretroviral therapy among injection drug users. AIDS. 2001; 15(17):2311-6. Available
Galea S, Ahern J, Freudenberg N, Vlahov D. Needle exchange programs and experience of violence in an inner city neighborhood. JAIDS: Journal of Acquired Immune Deficiency Syndromes. 2001; 28(3):282-8. Available
Phelps RM,...Vlahov D, et al. Cancer incidence in women with or at risk for HIV. International Journal of Cancer. 2001; 94(5):753-7.
Vlahov D, et al. Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy. American Journal of Epidemiology. 2001; 154(12 Suppl):S70-7. Available
Latka M. Female-initiated barrier methods for the prevention of STI/HIV: Where are we now? Where should we go?. Journal of Urban Health: Bulletin of The New York Academy of Medicine. 2001; 78(4):571-80. Available
2000 Publications
Chitnis A, Rawls D, Moore J. Origin of HIV type 1 in colonial French Equatorial Africa?. AIDS Research and Human Retroviruses. 2000; 16(1):5-8. Available
Thio CL,... Vlahov D, et al. Screening for hepatitis C virus in human immunodeficiency virus-infected individuals. Journal of Clinical Microbiology. 2000; 38(2):575-7.
Zwahlen M,... Vlahov D, et al. HIV testing and retesting for men and women in Switzerland. European Journal of Epidemiology. 2000; 16(2):123-33. Available
Doherty MC,... Vlahov D. Correlates of HIV infection among young adult short-term injection drug users. AIDS. 2000; 14(6):717-26. Available
Tang AM,... Vlahov D. Improved antioxidant status among HIV-infected injecting drug users on potent antiretroviral therapy. JAIDS: Journal of Acquired Immune Deficiency Syndromes. 2000; 23(4):321-6. Available
Ahdieh L..., Vlahov D, et al. Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women. American Journal of Epidemiology. 2000; 151(12):1148-57. Available
Greenberg B, McCorkle R, Vlahov D, et al. Palliative care for HIV disease in the era of highly active antiretroviral therapy. Journal of Urban Health: Bulletin of The New York Academy of Medicine. 2000; 77(2):150-65. Available
Gollub EL...,Latka M, et al. A randomized trial of hierarchical counseling in a short, clinic-based intervention to reduce the risk of sexually transmitted diseases in women. AIDS. 2000; 14(9):1249-55. Available
Carrieri MP, Vlahov D, et al. Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART. The Manif-2000 Study Group. Drug and Alcohol Dependence. 2000; 60(1):51-4. Available
An P..., Vlahov D, et al. Influence of CCR5 promoter haplotypes on AIDS progression in African-Americans. AIDS. 2000; 14(14):2117-22. Available
Monterroso ER,...Vlahov D, et al. Prevention of HIV infection in street-recruited injection drug users. The Collaborative Injection Drug User Study (CIDUS). JAIDS: Journal of Acquired Immune Deficiency Syndrome. 2000; 25(1):63-70.
Coffin PO. Syringe availability as HIV prevention: a review of modalities. Journal of Urban Health: Bulletin of The New York Academy of Medicine. 2000; 77(3):306-30. Available
Shah NG,... Vlahov D, et al. Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus. AIDS. 2000; 14(13):2035-43. Available
Mantell JE, Scheepers E, Karim QA. . Introducing the female condom through the public health sector: experiences from South Africa. AIDS Care. 2000; 12(5):589-601. Available
Shin HD,...Vlahov D, et al.. Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proceedings of the National Academy of Sciences of the United States of America. 2000; 97(26):14457-72. Available
Song JY... Vlahov D. The prevalence of homelessness among injection drug users with and without HIV infection. Journal of Urban Health: Bulletin of The New York Academy of Medicine. 2000; 77(4):678-87. Available
1999 Publications
IN: Directions in HIV Service Delivery and Care. A Policy Brief. Number 1.
Washington, DC: Department of Health and Human Services, 1999.
Available
New York: Bureau of HIV Prevention, New York City Department of Health, 1999.
Available
Klein RS, Flanigan T, Schuman P, Smith D, Vlahov D. Criteria for assessing cutaneous anergy in women with or at risk for HIV infection. HIV Epidemiologic Research Study Group. Journal of Allergy and Clinical Immunology. 1999; 103 (1 Pt 1):93-8. Available
Carrieri MP,... Vlahov D, et al.. Access to antiretroviral therapy among French HIV-infected drug users (IDUs): the influence of continued drug use. MANIF 2000 Study Group. Journal of Epidemiology and Community Health. 1999; 53(1):4-8.
Lyles CM,...Vlahov D, et al. Cell-associated infectious HIV-1 viral load as a predictor of clinical progression and survival among HIV-1 infected injection drug users and homosexual men. European Journal of Epidemiology. 1999; 15(2):99-108. Available
Carrington M,... Vlahov D, et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science. 1999; 283(5408):1748-52. Available
Pezzotti P,...Vlahov D, et al. Direct comparison of time to AIDS and infectious disease death between HIV seroconverter injection drug users in Italy and the United States: results from the ALIVE and ISS studies. AIDS Link to Intravenous Experiences. Italian Seroconversion Study. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1999; 20(3):275-82. Available
Carneiro M, Fuller C, Doherty MC, Vlahov D. HIV prevalence and risk behaviors among new initiates into injection drug use over the age of 40 years old. Drug and Alcohol Dependence. 1999; 54(1):83-6. Available
Rompalo AM,... Vlahov D, et al. Comparison of clinical manifestations of HIV infection among women by risk group, CD4+ cell count, and HIV-1 plasma viral load. HER Study Group. HIV Epidemiology Research. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1999; 20(5):448-54. Available
van Ameijden EJ, Krol A, Vlahov D, Flynn C, van Haastrecht HJ, Coutinho RA. Pre-AIDS mortality and morbidity among injection drug users in Amsterdam and Baltimore: an ecological comparison. Substance Use and Misuse. 1999; 34(6):845-65.
Klevens RM, Diaz T, Flemming PL, Mays MA, Frey R.. Trends in AIDS among Hispanics in the United States, 1991-1996. American Journal of Public Health. 1999; 89(7):1104-6. Available
Dean M,... Vlahov D, et al. Reduced risk of AIDS lymphoma in individuals heterozygous for the CCR5-delta32 mutation. Cancer Research. 1999; 59(15):3561-4. Available
Garfein RS, Lyerla R, Jones TS, Nakashima AK, Monterroso ER, Vlahov D. Re: "High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study". American Journal of Epidemiology. 1999; 150(3):325-6. Available
Klein RS, Flanigan T, Schuman P, Smith D, Vlahov D. The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing. HER Study Group. HIV Epidemiology Research. International Journal of Tuberculosis and Lung Disease. 1999; 3(8):681-8.
Flanigan TP,... Vlahov D, et al. Self-reported bacterial infections among women with or at risk for human immunodeficiency virus infection. Clinical Infectious Diseases. 1999; 29(3):608-12. Available
Sterling TR,... Vlahov D, et al. Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among seroconverters. Journal of Infectious Diseases. 1999; 180(3):666-72. Available
Lyles CM,... Vlahov D, et al. Longitudinal human immunodeficiency virus type 1 load in the Italian seroconversion study: correlates and temporal trends of virus load. Journal of Infectious Diseases. 1999; 180(4):1018-24. Available
Carneiro M,... Vlahov D, et al.. The effect of drug-injection behavior on genetic evolution of HIV-1. Journal of Infectious Diseases. 1999; 180(4):1025-32. Available
Rich JD,... Vlahov D. Prevalence and incidence of HIV among incarcerated and reincarcerated women in Rhode Island. JAIDS: Journal of Acquired Immune Deficiency Syndromes. 1999; 22(2):161-6. Available
Cu-Uvin S,...Vlahov D, et al. Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group. Clinical Infectious Diseases. 1999; 29(5):1145-50. Available
Greenberg B, Berkman A, Thomas R, Hoos D, Finkelstein R, Astemborski J, Vlahov D.. Evaluating supervised HAART in late-stage HIV among drug users: a preliminary report. Journal of Urban Health: Bulletin of The New York Academy of Medicine. 1999; 76(4):468-80. Available
1998 Publications
IN: Encyclopedia of AIDS : a social, political, cultural, and scientific record of the HIV epidemic.
(ed.) by Raymond A. Smith
Chicago: Fitzroy Dearborn, 1998.
Available
Diaz T, et al. Injection and syringe sharing among HIV-infected injection drug users: implications for prevention of HIV transmission. Supplement to HIV/AIDS Surveillance Group. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998; 18 Suppl 1:S76-81. Available
Levin BW...,Fleischman AR.. HIV in the NICU: Results of the 1996 survey of the Section on Perinatal Pediatrics, American Academy of Pediatrics. Pediatrics. 1998; 102(3 Pt 2 of 2):775. Available
Susser E, et al.. Human immunodeficiency virus sexual risk reduction in homeless men with mental illness. Archives of General Psychiatry. 1998; 55(3):266-72. Available
Susser E, et al. Reporting sexual risk behavior for HIV: a practical risk index and a method for improving risk indices. American Journal of Public Health. 1998; 88(4):671-4. Available
Wittkowski KM, Susser E, Dietz K. The protective effect of condoms and nonoxynol-9 against HIV infection. American Journal of Public Health. 1998; 88(4):590-6. Available
Stein GL, Fleischman AR.. Addiction treatment: promoting a medical approach to substance use. Journal of Urban Health: Bulletin of The New York Academy of Medicine. 1998; 75(3):558-83. Available
1997 Publications
1997.
Collins PY,... Stein GL.. The potential of female-controlled methods of HIV prevention for women with mental illness. Health Psychologist. 1997; 18(4):9,20-21.
Stein GL, et al.. Attorneys and social workers collaborating in HIV care: Breaking new ground. Fordham Urban Law Journal. 1997; XXIV(3):533-566.
Valenti WM, Stein GL.. Undergraduate education on HIV/AIDS. Academic Medicine: Journal of the Association of American Medical Colleges. 1997; 72(5):319. Available
Shaw-Taylor Y, Andrulis DP. AIDS in the developed world: implications for the provision and financing of care. AIDS. 1997; 11(11):1305-9. Available
Rezza G,...Vlahov D, et al. Markers of response to zidovudine monotherapy among treated HIV seroconverters. Italian Seroconversion Study. Antiviral Therapy. 1997; 167-74: Available
1996 Publications
Stein GL, et al.. Forum on prisoners' access to clinical trials: summary of recommendations. AIDS & Public Policy Journal. 1996; 11(1):3-20. Available
Susser E, et al. Injection drug use and risk of HIV transmission among homeless men with mental illness. American Journal of Psychiatry. 1996; 153(6):794-8. Available
1995 Publications
Stein GL.. Introduction: perspectives in HIV care: a view from the front lines. Bulletin of the New York Acadademy of Medicine. 1995; 71(1 suppl):173-7. Available
Levin BW,... Fleischman AR.. The treatment of non-HIV-related conditions in newborns at risk for HIV: a survey of neonatologists. American Journal of Public Health. 1995; 85(11):1507-13. Available
1994 Publications
Stein GL.. Tuberculosis and HIV: Guidelines for community-based HIV service providers. AIDS & Public Policy Journal. 1994; 9:214-228. Available
Note: Bibliographic citations are received directly from the authors and may not reflect the exact citations of the actual published works.
